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Wearable devices to detect changes in health 
status are increasingly adopted by consumers, yet 
hospitals remain slow to assimilate these devices into 
clinical practice. Despite the clear benefits of 
capturing clinical information in acutely ill patients, 
such technology remains difficult to implement in 
emergency medicine. To improve adoption, barriers 
must first be removed. In our technical feasibility and 
acceptability trial, we studied the deployment of a 
wearable wireless biosensor that collects 
physiological data. We enrolled 44 adult patients 
receiving care in an emergency department 
observation unit. After we consented patients for 
participation, we applied biosensors to their chest and 
collected basic demographic and clinical information. 
We then collected biosensor data on an isolated 
system and measured patient experience via an exit 
survey. Throughout this process we documented and 
studied technical challenges. Overall, the technology 
was feasible to deploy in the emergency department 
observation unit and was acceptable to participants. 
Such technologies have tremendous future operational 
and clinical implications in settings ranging from 
emergency to home-care.  
 
 
1. Introduction  
 
Increased use of heart rate monitors, smartphone 
health apps and cutaneous wearable monitors provide 
unobtrusive, important insights into health 
conditions.1 Paired devices and companion 
smartphone apps can detect rhythm changes in 
individuals with atrial fibrillation, measure adherence 
to oral medications and track changes in spirometry in 
individuals with lung disease.2-5 Despite successful 
demonstration projects that indicate the feasibility of 
using wearable devices to measure vital sign 
parameters, there has been minimal adoption of 
wearable devices for clinical use in the emergency 
department.6 
Emergency departments face rising volumes and 
increasingly ill patients. In acute settings, 
understanding the context prior to the presentation of 
a critically ill patient can help make a diagnosis while 
providing important information that may guide 
medical management.6,7 Unobtrusive wearable 
devices have the potential to change not only the 
management of patients in the emergency department, 
but also practices in patient throughput and decisions 
to admit or discharge patients through more frequent 
monitoring and under ambulatory conditions.8 
While some investigations suggest that capturing 
these real-time biophysiologic changes may alter 
certain health decisions (e.g., detection of arrhythmia 
may alter the decision to initiate anticoagulation 
pharmacotherapy), few hospitals have consistently 
integrated wearable devices into their inpatient 
practice.9 The delay in introduction of wearable 
devices in the hospital setting is likely due to 
significant information security and wireless data 
transmission capability challenges that limit 
integration with hospital data solution systems. 
Wireless biosensors that capture important vital 
sign information may improve detection of adverse 
events in the outpatient setting and may serve as a 
vehicle to conduct traditional inpatient care at home in 
the setting of a “home hospital” system.10 There is 





   
 
   
 
additional benefit of translating the experience of 
wearable biosensors from the outpatient setting into 
the hospital, especially the emergency department. 
Wearable biosensors can improve a hospital’s capacity 
to conduct telemetry in non-traditional settings, 
provide safer quality care, and improve the patient 
hospital experience. Despite the benefits of developing 
and using wearable biosensors in the hospital, there are 
significant barriers that must be overcome prior to 
successful deployment of these devices. In this 
manuscript, we discuss our experience with 
information technology challenges, biosensor design 
considerations and human factors issues that affect the 
successful deployment of a wearable biosensor 
system. 
 
2. Materials and Methods 
 
We conducted a technical feasibility trial that 
deployed a prototype wireless wearable biosensor in 
the emergency department observation unit (EDOU) 
of an urban, academic, quaternary care center. Our 
emergency department has an annual volume of 
63,000 patients per year, 5-10% of which receive care 
in an integrated EDOU annually. The EDOU is 
designed to function like a short-stay hospital unit and 
manages patients who have projected hospital stays of 
up to 48 hours. The intention of the unit is to provide 
additional time beyond a typical emergency 
department visit for additional diagnostic and 
therapeutic interventions for patients who may 
otherwise not require an inpatient admission in our 
hospital. Our investigation was approved by the 
Partners Healthcare Institutional Review Board. We 
enrolled adult emergency department patients who 
were assigned by the primary clinical team to the 
EDOU.  
 
2.1. Wearable Biosensor and Connectivity 
 
We deployed a single-use, cutaneous, chest-worn 
investigational biosensor that collects physiological 
data and contextual parameters consisting of heart 
rate, respiratory rate, activity level, activity type, and 
posture (Philips Connecting Sensing, Cambridge, 
MA) (Figure 1).8 The biosensor is made of disposable 
foam with a hydrocolloid adhesive that houses a 
lithium coin battery, Bluetooth Low Energy (BLE) 
radio, accelerometer, and two hydrogel-based 
electrocardiogram (ECG) electrodes. An advanced 
hydrocolloid adhesive allows the biosensor to adhere 
to human skin and is designed to minimize irritation 
while maximizing adhesion. A previous version of this 
biosensor had been demonstrated to record respiratory 
rate in emergency department patients.8 Iterative 
refinements of the original version of the wearable 
biosensor had been integrated into the novel version 
used in this investigation. 
 
 
Figure 1: A cutaneous, wearable biosensor, the Philips 
BX100. 
 
The wireless wearable biosensors are connected to 
a Wi-Fi network in the EDOU via two BLE routers 
and a wireless access point installed in the ceiling of 
the EDOU. We elected to utilize a separate BLE 
network with wireless access point to prevent the 
wearable sensors from communicating with our 
hospital network. This step ensured that critical 
clinical patient data could not be interdicted by 
malicious software using the biosensor as a bridge. 
Proprietary software (access controller software and 
business logic software) installed on the physical 
servers at the EDOU nurses’ station provides 
management of connected biosensors and facilitates 
communication with the clinical research database. A 
clinical research mobile application installed on a 
tablet computer provides a clinician interface for 
patient assignment and review of biosensor data. 
 
2.2. Eligibility and Consent 
 
English speaking patients, ages 18 and older, 
receiving care in the EDOU were eligible for this 
study. We enrolled patients between April and June of 
2019. We identified potential participants through 
passive screening of the electronic medical record 
(EMR). The research team approached potentially 
eligible participants and confirmed eligibility criteria. 
We obtained written informed consent from interested 
participants. 
 
2.3. Study Procedures 
 
Consented patients underwent a skin assessment 
and skin preparation procedure (similar to routine 
ECG lead preparation) prior to biosensor placement. 
We collected a brief medical history and demographic 
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information prior to biosensor placement and patients 
received a wristband to indicate study participation. 
Enrollment began at the time of biosensor placement. 
We placed biosensors on the upper left chest and 
patients wore the device for the full duration of their 
EDOU stay. If a patient's stay in the EDOU exceeded 
24 hours, study staff performed daily device adhesion 
and skin assessments. During study participation, 
patients were free to move in and out of the EDOU 
without limitation. Before patient discharge from the 
EDOU, study staff removed the biosensor and 
performed a post-removal skin assessment. 
Participants were asked to complete the Participant 
Experience Questionnaire, a seven-question survey 
aimed to rate the overall experience and level of 
comfort of wearing the biosensor. Participants who 
successfully completed all protocol-required activities 
were compensated with a $50 gift card. 
 
 
Figure 2: Study schema 
 
2.4 Data Collection and Analysis 
 
The research team collected and recorded clinical 
data team on paper case report forms (CRFs) and then 
transcribed into the Datatrak Electronic Data Capture 
(EDC) system.11 Datatrak is a secure, web-based EDC 
system that allows for capture and delivery of data 
with advanced reporting and optimized workflow. 
We collected basic demographic information on all 
study participants and calculated basic descriptive 
statistics.  
We collected biosensor data in a separate research 
database to enable analysis related to the technology 




During the study period, 290 patients were 
screened, and 52 individuals met eligibility criteria 
and were approached by a member of the research 
team regarding participation. Of those, 86.5% (n=45) 
consented to participate in the study. Of the 45 patients 
consented to the study, 44 patients were enrolled and 
40 patients completed all protocol-required study 
activities. Four participants were unable to complete 
the study due to incomplete data (e.g., biosensor 
applied for less than 12 hours, participant requested 
withdrawal from the study, and enrolled participant 
but no biosensor applied given an alternative triage 
decision outside of EDOU. 
 
 
Figure 3: Enrollment of study participants 
 
The majority of enrolled patients were white 
females (56.8%) (Table 1). Eighty-two percent (n=36) 
of patients enrolled in the study were discharged to 
home from the EDOU, and the average length of stay 
in the EDOU was 23.7 hours.  
  
Gender 
 Male, n (%) 19 (43.2%) 
 Female 25 (56.8%) 
Race 
 White 31 (70.5%) 
 Black or African American 6 (13.6%) 
 Asian 2 (4.5%) 
 Other 5 (11.4%) 
Ethnicity 
 Hispanic or Latino 7 (15.9%) 
 Non-Hispanic or Latino 37 (84.1%) 
Average Age (Years) 
 Mean (±SD) 54.0 (20.1) 
 Median 53.5 
 Min, Max (21, 84) 
BMI (kg/m2) 
 Mean (±SD) 30.3 (8.7) 









































   
 
   
 
 Min, Max (20.2, 61.6) 
Table 1. Participant characteristics 
 
We were able to successfully place the wireless 
wearable biosensors on study participants, connect the 
sensor to the network, and collect 12 hours of 
biosensor data 93.2% (n=41) times.  In 5.9% (n=3) 
instances, we were not able to successfully connect the 
sensor to the installed network and the initial biosensor 
was replaced with a new device. For seven of our 
enrollments, we also noted that we were unable to 
connect the tablet to the installed network. We noted 
that the data server placed under a work desk had been 
unplugged. We power reset and rebooted the system, 
which then acquired a signal from established 
biosensors. When the network was inactive, the 
established biosensors stored data locally to upload to 
the server when connectivity was restored. Across all 
biosensors used in the study, 0.1% (SD=0.2) of 
calculated observations were not uploaded to the 
server due to network latency. 
 
 
3.2 Participant Experience Questionnaire 
 
After biosensor removal and skin assessment, 
participants completed the Participant Experience 
Questionnaire. This questionnaire is comprised of six 
questions that asked participants to rate their overall 
experience and comfort level wearing the biosensor 
during their stay in the EDOU. Overall, 93.2% of 
patients reported that they experienced no discomfort 
during the time that they were wearing the device; 
90.9% of patients said they would wear the device 
again. Results of the Participant Experience 
Questionnaire are shown in Table 2. 
 
Experienced discomfort 
during placement of device 
None: 100% (n=44) 
Experienced discomfort 
while wearing device 
None: 93.2% (n=41) 
Minimal: 2.3% (n=1) 
Missing data: 4.5% 
(n=2) 
Experienced discomfort 
during device removal 
None: 59.1% (n=26) 
Minimal: 27.3% 
(n=12) 
Mild: 2.3% (n=1) 
Moderate: 4.5% (n=2) 
Severe: 2.3% (n=1) 




None: 93.2% (n=41) 
Mild: 2.3% (n=1) 
Missing data: 4.5% 
(n=2) 
Power button clicking was 
noticeable 
No: 95.5% (n=42) 
Missing data: 4.5% 
(n=2) 
Would wear the device 
again 
Yes: 90.9% (n=40) 
No: 4.5% (n=2) 
Missing data: 4.5% 
(n=2) 
Table 2: Patient Experience Questionnaire 
 
4. Discussion  
 
This investigation demonstrates that a wireless 
wearable biosensor that collects physiological data 
and contextual parameters is feasible to deploy in an 
EDOU. We additionally demonstrated that patients are 
accepting of biosensors and are willing to wear them 
in this setting. One of our most important findings was 
the high degree of multidisciplinary collaboration 
needed to deploy a wireless biosensor system in the 
emergency department. These results suggest that the 
deployment of a wireless wearable biosensor system 
in this setting is feasible. Our deployment roadmap 
may be used by others seeking to use similar 
technology in hospital settings. 
Participants in the study were accepting of the use 
of cutaneous wireless wearable biosensors during their 
emergency department stay. They considered the 
device unobtrusive and comfortable. Participants did 
not feel inconvenienced by wearing the device, and 
most would be willing to wear a biosensor during their 
emergency department stay. Additionally, we were 
able to train research assistants to apply and connect 
the biosensor to the wireless network. In the future, 
patients who enter the emergency department may be 
able to have the biosensor placed by nursing staff or a 
medical assistant during their initial triage, either in 
the waiting room or inside the emergency department. 
In aggregate, this data suggests that the sensor is easy 
to operate, and patients who may need supplementary 
monitoring in the emergency department will wear 
these devices or similar devices.  
The success of this investigation relied on close 
collaboration with staff from information security, 
hospital engineering, emergency department 
operations as well as research staff. We recommend 
early engagement with hospital information security 
personnel. Initial deployment considerations such as 
where to place devices on a hospital network can take 
time to elucidate. There are advantages in integrating 
biosensors into existing networks—they allow for 
easy integration into hospital workflows and allow 
nascent investigations to understand potential 
deficiencies in signal transmission. At the same time, 
integration into a secure hospital network may be 
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time-consuming and beyond the scope of an initial 
feasibility demonstration project. In response, we 
recommend consideration of alternative data 
collection and integration measures. These may 
include installing a separate, independent network in a 
small portion of the study site or enabling passive data 
collection from biosensors using low energy Bluetooth 
or active radiofrequency identification systems. These 
systems may represent a novel workflow where the 
isolation of biosensor data allows for a wireless 
biosensor system to continue to function in the event 
of network downtime. 
In this investigation, we decided, in collaboration 
with our hospital information security specialists, to 
install an independent wireless network to 
accommodate the biosensor. This approach required 
us to interface with our hospital’s engineering group 
in order to install a simple network consisting of two 
routers and a series of data servers. Like most hospital 
emergency departments, we are constrained by space, 
and the integration of these devices among the ebb and 
flow of patient volume, nursing and provider 
workflows was critical. We ultimately feel our 
solution was advantageous since it allowed us to 
isolate biosensor data from other clinical data in the 
emergency department and enabled us to assess for 
potential disruptions in data transmission from 
biosensor to network.  
 
4.1. Implications of this work 
 
There are several important implications to this 
work. First, the deployment of wearable biosensors 
may alter the method in which emergency 
department’s triage and deliver care to patients that 
traditionally needed a wired monitor. For example, 
patients with high-risk chief complaints like chest 
pain, palpitations, or shortness of breath typically 
require a room in the emergency department or 
hallway bed with a wired monitor to measure dynamic 
changes in heart rate, oxygen saturation, or respiratory 
rate. The potential to expand the footprint within the 
emergency department in which these patients can be 
monitored and cared for may allow emergency 
departments to think about where these patients are 
roomed (e.g., they could potentially be cared for in 
spaces that traditionally did not have wired monitors).   
Second, independent wireless networks can be 
installed to cover the emergency department and 
waiting room. This setup permits wireless, 
unobtrusive physiological data transmission to be 
initiated at initial triage of emergency department 
patients. Current emergency medicine triage practices 
rely on emergency department staff obtaining vital 
signs as patients register in the waiting room. 
Depending on the emergency severity index (ESI) 
assigned to the patient, the presence of beds in the 
emergency department and availability of providers, 
patients may wait for extended periods in the waiting 
room. The wireless wearable biosensors could be 
deployed among waiting room patients to detect 
potential changes in physiology that may necessitate 
an “up triage” or potential change in ESI and 
subsequent rapid entry into the emergency department. 
Finally, now that we have established the 
feasibility of deploying wireless biosensors in the 
emergency department, our next steps are to 
understand the impact on clinical operations and care 
that a wireless biosensor may have in emergency 
medicine. Although data can be collected on patients 
in the emergency department, an infrastructure to 
respond and manage the additional numbers of 
potential care areas that are enabled through a wireless 
and unobtrusive biosensor needs to be developed and 
studied. 
 
4.2. Limitations and future work.  
 
This investigation had several limitations. First, we 
deployed the wearable biosensor in a single, urban, 
academic emergency department. Our experience with 
designing and implementing this study may vary in 
community emergency departments or other hospital 
locations. Because we wanted to demonstrate that the 
use of the biosensor system was feasible, we did not 
study methods in which biosensor data should be 
integrated into clinical workflow. We also did not test 
the accuracy of data collected from the biosensor. 
Finally, we did not consider the cost of installing the 
infrastructure necessary to utilize the sensor. We 
installed two routers and a small, off-the-shelf data 
server to support the flow of biosensor data in the 
study. Future investigations should include an 
economic analysis on the financial feasibility of such 
a system. 
In the future, we anticipate investigating 
operational factors that allow for the integration of 
wearable biosensor data into emergency department 
workflows. This is of particular interest to us as 
emergency department patients may move through 
various departments in order to obtain imaging studies 
and other procedures during their emergency 
department stay. It will be important to understand 
how biosensors are applied and how consultants are 
notified of the presence of the sensor. We also plan to 
understand how the biosensor can be used during the 
transition from emergency department to inpatient, 




   
 
   
 
 
Overall, this study demonstrated that a wireless 
wearable biosensor system is a feasible technology to 
deploy in the emergency department. Participants who 
wore the biosensor were accepting of the biosensors 
and reported that it was comfortable; we experienced 
no serious adverse reactions to the biosensor. We were 
able to successfully place biosensors and acquire 
signal 93.2% of the time. This investigation lays the 
foundation for future studies that will understand how 
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